Literature DB >> 21732013

Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus.

Gillian M Air1, Jingqi Feng, Tao Chen, Michelle L Joachims, Judith A James, Linda F Thompson.   

Abstract

INTRODUCTION: The 2009 swine-origin H1N1 influenza virus (swH1N1) provided an opportunity to study immune responses to a new influenza strain in the context of seasonal influenza vaccination. Our goals were: to assess whether analyzing multiple parameters of immune responsiveness to influenza has an advantage over evaluating hemagglutination inhibition (HAI) titer alone, to determine whether vaccination with the seasonal vaccine induced cross-reactive immunity to swH1N1 in some individuals, and to determine whether the immune response against swH1N1 is higher after infection than vaccination.
METHODS: Antibody and T cell responses were studied in ten subjects who were first immunized with the 2009-2010 seasonal influenza subunit vaccine, then 6 weeks later with the swH1N1 monovalent subunit vaccine. The amount of antibody against native virus glycoproteins, overall avidity of these antibodies, and HAI titer were measured. T cells were evaluated for proliferation and IFNγ secretion in response to the vaccine in vitro. Individuals with influenza-like illness were also evaluated, adding a microplate neuraminidase inhibition (NAI) test.
RESULTS: The immune response to influenza was highly variable and immune parameters did not increase in parallel. The seasonal vaccine induced antibodies recognizing the pandemic virus in 50% of subjects. Antibody affinity and NAI activity to swH1N1 were higher after natural infection than vaccination.
CONCLUSIONS: The evaluation of several immune parameters gives a more complete measure of immune responsiveness to influenza infection or vaccination than the HAI test alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732013      PMCID: PMC3197711          DOI: 10.1007/s10875-011-9563-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  31 in total

1.  Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets.

Authors:  Ji-Young Min; Grace L Chen; Celia Santos; Elaine W Lamirande; Yumiko Matsuoka; Kanta Subbarao
Journal:  Virology       Date:  2010-12-05       Impact factor: 3.616

2.  Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.

Authors:  Jonathan A McCullers; Lee-Ann Van De Velde; Kim J Allison; Kristen C Branum; Richard J Webby; Patricia M Flynn
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

3.  Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus.

Authors:  Katherine A Richards; David Topham; Francisco A Chaves; Andrea J Sant
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

4.  A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.

Authors:  Kawsar R Talaat; Michael E Greenberg; Michael H Lai; Gunter F Hartel; Christine H Wichems; Steven Rockman; Robert J Jeanfreau; M Rita Ghosh; Martin L Kabongo; Charmaine Gittleson; Ruth A Karron
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

5.  Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.

Authors:  Gannon C Mak; Perrin W W Choy; W Y Lee; Ann H Wong; K C Ng; Wilina Lim
Journal:  J Med Virol       Date:  2010-11       Impact factor: 2.327

6.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

7.  Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population.

Authors:  Chia-Yu Chi; Ching-Chuan Liu; Chia-Chun Lin; Hsuan-Chen Wang; Yung-Tsung Cheng; Chung-Ming Chang; Jen-Ren Wang
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

8.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

9.  Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets.

Authors:  A H Ellebedy; M F Ducatez; S Duan; E Stigger-Rosser; A M Rubrum; E A Govorkova; R G Webster; R J Webby
Journal:  Vaccine       Date:  2010-09-15       Impact factor: 3.641

10.  Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.

Authors:  Gwendolyn L Gilbert; Michelle A Cretikos; Linda Hueston; George Doukas; Brian O'Toole; Dominic E Dwyer
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

View more
  6 in total

Review 1.  Immunological assessment of influenza vaccines and immune correlates of protection.

Authors:  Adrian Reber; Jacqueline Katz
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

2.  CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.

Authors:  Jennifer L Nayak; Theresa F Fitzgerald; Katherine A Richards; Hongmei Yang; John J Treanor; Andrea J Sant
Journal:  J Infect Dis       Date:  2012-11-12       Impact factor: 5.226

Review 3.  Influenza neuraminidase.

Authors:  Gillian M Air
Journal:  Influenza Other Respir Viruses       Date:  2011-11-16       Impact factor: 4.380

4.  Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine.

Authors:  David A G Skibinski; Leigh Ann Jones; Yuan O Zhu; Lin Wu Xue; Bijin Au; Bernett Lee; Ahmad Nazri Mohamed Naim; Audrey Lee; Nivashini Kaliaperumal; Jenny G H Low; Lawrence S Lee; Michael Poidinger; Philippe Saudan; Martin Bachmann; Eng Eong Ooi; Brendon J Hanson; Veronica Novotny-Diermayr; Alex Matter; Anna-Marie Fairhurst; Martin L Hibberd; John E Connolly
Journal:  Sci Rep       Date:  2018-12-20       Impact factor: 4.379

5.  Regulation of influenza A virus infection by Lnc-PINK1-2:5.

Authors:  Samuel Pushparaj; Zhengyu Zhu; Chaoqun Huang; Sunil More; Yurong Liang; Kong Lin; Kishore Vaddadi; Lin Liu
Journal:  J Cell Mol Med       Date:  2022-02-24       Impact factor: 5.310

6.  Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.

Authors:  Ma Teresa Herrera; Yolanda Gonzalez; Esmeralda Juárez; Fernando Hernández-Sánchez; Claudia Carranza; Carmen Sarabia; Silvia Guzman-Beltran; Ma Eugenia Manjarrez; Marcela Muñoz-Torrico; Lourdes Garcia-Garcia; Eduardo Sada; Martha Torres
Journal:  BMC Infect Dis       Date:  2013-11-15       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.